Omalizumab Is Associated with Reduced Acute Severity of Rhinovirus-triggered Asthma Exacerbation.
作者信息
Kantor David B, McDonald Molly C, Stenquist Nicole, Schultz Blake J, Smallwood Craig D, Nelson Kyle A, Phipatanakul Wanda, Hirschhorn Joel N
机构信息
1 Boston Children's Hospital Boston, Massachusetts.
2 Harvard Medical School Boston, Massachusetts and.
出版信息
Am J Respir Crit Care Med. 2016 Dec 15;194(12):1552-1555. doi: 10.1164/rccm.201606-1145LE.
Abstract
摘要
相似文献
1
Omalizumab Is Associated with Reduced Acute Severity of Rhinovirus-triggered Asthma Exacerbation.
Am J Respir Crit Care Med. 2016 Dec 15;194(12):1552-1555. doi: 10.1164/rccm.201606-1145LE.
2
Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma.
Am J Respir Crit Care Med. 2017 Oct 15;196(8):985-992. doi: 10.1164/rccm.201701-0120OC.
3
Real-life long-term omalizumab therapy in children with severe allergic asthma.
Eur Respir J. 2015 Sep;46(3):856-9. doi: 10.1183/09031936.00008115. Epub 2015 May 28.
4
Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab.
J Allergy Clin Immunol. 2018 May;141(5):1735-1743.e9. doi: 10.1016/j.jaci.2017.07.035. Epub 2017 Sep 1.
5
Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy.
Allergol Int. 2015 Oct;64(4):364-70. doi: 10.1016/j.alit.2015.05.006. Epub 2015 Jun 10.
6
The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study.
PLoS One. 2017 Aug 31;12(8):e0183869. doi: 10.1371/journal.pone.0183869. eCollection 2017.
7
Omalizumab could be effective in children with severe eosinophilic non-allergic asthma.
Pediatr Allergy Immunol. 2018 Feb;29(1):90-93. doi: 10.1111/pai.12813. Epub 2017 Nov 20.
8
Omalizumab in severe asthma: Evaluation of the clinical impact after its withdrawal.
Rev Port Pneumol (2006). 2017 Mar-Apr;23(2):108-109. doi: 10.1016/j.rppnen.2016.12.004. Epub 2017 Feb 13.
9
Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma.
J Investig Allergol Clin Immunol. 2017;27(6):388-391. doi: 10.18176/jiaci.0196.
10
[Omalizumab and allergen immunotherapy: A clinical report and review of the literature].
Rev Mal Respir. 2019 Feb;36(2):191-196. doi: 10.1016/j.rmr.2018.03.006. Epub 2018 Nov 3.
引用本文的文献
1
The Direct and Indirect Role of IgE on Airway Epithelium in Asthma.
Allergy. 2025 Apr;80(4):919-931. doi: 10.1111/all.16459. Epub 2025 Feb 18.
2
The Possible Roles of IL-4/IL-13 in the Development of Eosinophil-Predominant Severe Asthma.
Biomolecules. 2024 May 2;14(5):546. doi: 10.3390/biom14050546.
3
COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)-a Randomized Controlled Clinical Trial.
Open Forum Infect Dis. 2024 Feb 23;11(4):ofae102. doi: 10.1093/ofid/ofae102. eCollection 2024 Apr.
4
The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma.
Eur Respir J. 2024 Apr 4;63(4). doi: 10.1183/13993003.01397-2023. Print 2024 Apr.
5
Rhinovirus induces airway remodeling: what are the physiological consequences?
Respir Res. 2023 Sep 29;24(1):238. doi: 10.1186/s12931-023-02529-9.
6
Histamine-releasing factor in severe asthma and rhinovirus-associated asthma exacerbation.
J Allergy Clin Immunol. 2023 Sep;152(3):633-640.e4. doi: 10.1016/j.jaci.2023.04.021. Epub 2023 Jun 8.
7
Inhaled drug delivery for the targeted treatment of asthma.
Adv Drug Deliv Rev. 2023 Jul;198:114858. doi: 10.1016/j.addr.2023.114858. Epub 2023 May 12.
8
Viral Infection and Airway Epithelial Immunity in Asthma.
Int J Mol Sci. 2022 Aug 31;23(17):9914. doi: 10.3390/ijms23179914.
9
Innate Immune Responses by Respiratory Viruses, Including Rhinovirus, During Asthma Exacerbation.
Front Immunol. 2022 Jun 20;13:865973. doi: 10.3389/fimmu.2022.865973. eCollection 2022.
10
Immunoglobulin E-Dependent Activation of Immune Cells in Rhinovirus-Induced Asthma Exacerbation.
Front Allergy. 2022 Feb 22;3:835748. doi: 10.3389/falgy.2022.835748. eCollection 2022.
本文引用的文献
1
Rhinovirus and serum IgE are associated with acute asthma exacerbation severity in children.
J Allergy Clin Immunol. 2016 Nov;138(5):1467-1471.e9. doi: 10.1016/j.jaci.2016.04.044. Epub 2016 Jun 15.
2
Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations.
J Allergy Clin Immunol. 2015 Dec;136(6):1476-1485. doi: 10.1016/j.jaci.2015.09.008. Epub 2015 Oct 27.
3
Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE.
Regul Toxicol Pharmacol. 2015 Feb;71(1):68-77. doi: 10.1016/j.yrtph.2014.12.002. Epub 2014 Dec 8.
4
Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescents.
J Allergy Clin Immunol. 2012 Mar;129(3):694-701. doi: 10.1016/j.jaci.2011.12.962. Epub 2012 Jan 12.
5
Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.
N Engl J Med. 2011 Mar 17;364(11):1005-15. doi: 10.1056/NEJMoa1009705.
6
Predictors of symptoms are different from predictors of severe exacerbations from asthma in children.
Chest. 2011 Jul;140(1):100-107. doi: 10.1378/chest.10-2794. Epub 2011 Feb 3.
7
Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the Medication Adherence Report Scale for Asthma.
Ann Allergy Asthma Immunol. 2009 Oct;103(4):325-31. doi: 10.1016/s1081-1206(10)60532-7.
8
Severe exacerbations in children with mild asthma: characterizing a pediatric phenotype.
J Asthma. 2008 Aug;45(6):513-7. doi: 10.1080/02770900802017751.
9
Pediatric asthma admissions: chronic severity and acute exacerbations.
J Asthma. 2007 May;44(4):285-9. doi: 10.1080/02770900701340445.
10
An international observational prospective study to determine the cost of asthma exacerbations (COAX).
Respir Med. 2006 Mar;100(3):434-50. doi: 10.1016/j.rmed.2005.06.012. Epub 2005 Aug 11.
Zotero 插件